Correlation Between Halozyme Therapeutics and Liquidia Technologies
Can any of the company-specific risk be diversified away by investing in both Halozyme Therapeutics and Liquidia Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Halozyme Therapeutics and Liquidia Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Halozyme Therapeutics and Liquidia Technologies, you can compare the effects of market volatilities on Halozyme Therapeutics and Liquidia Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Halozyme Therapeutics with a short position of Liquidia Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Halozyme Therapeutics and Liquidia Technologies.
Diversification Opportunities for Halozyme Therapeutics and Liquidia Technologies
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Halozyme and Liquidia is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Halozyme Therapeutics and Liquidia Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Liquidia Technologies and Halozyme Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Halozyme Therapeutics are associated (or correlated) with Liquidia Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Liquidia Technologies has no effect on the direction of Halozyme Therapeutics i.e., Halozyme Therapeutics and Liquidia Technologies go up and down completely randomly.
Pair Corralation between Halozyme Therapeutics and Liquidia Technologies
Given the investment horizon of 90 days Halozyme Therapeutics is expected to generate 3.38 times less return on investment than Liquidia Technologies. But when comparing it to its historical volatility, Halozyme Therapeutics is 2.69 times less risky than Liquidia Technologies. It trades about 0.34 of its potential returns per unit of risk. Liquidia Technologies is currently generating about 0.43 of returns per unit of risk over similar time horizon. If you would invest 1,246 in Liquidia Technologies on November 9, 2024 and sell it today you would earn a total of 350.00 from holding Liquidia Technologies or generate 28.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Halozyme Therapeutics vs. Liquidia Technologies
Performance |
| Timeline |
| Halozyme Therapeutics |
| Liquidia Technologies |
Halozyme Therapeutics and Liquidia Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Halozyme Therapeutics and Liquidia Technologies
The main advantage of trading using opposite Halozyme Therapeutics and Liquidia Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Halozyme Therapeutics position performs unexpectedly, Liquidia Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Liquidia Technologies will offset losses from the drop in Liquidia Technologies' long position.| Halozyme Therapeutics vs. Agios Pharm | Halozyme Therapeutics vs. Insmed Inc | Halozyme Therapeutics vs. Ultragenyx | Halozyme Therapeutics vs. Biomarin Pharmaceutical |
| Liquidia Technologies vs. Biomarin Pharmaceutical | Liquidia Technologies vs. Vaxcyte | Liquidia Technologies vs. Legend Biotech Corp | Liquidia Technologies vs. Bio Techne Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |